CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 351 enrolled
Drug / intervention
Fluticasone furoate 50mcg +2 moredrug
Likely dose
Fluticasone furoate 50mcgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01436110
NCT01436110Phase 3Completed

A Randomised, Double-blind, Double-dummy, Placebo Controlled Multi-centre Study to Evaluate the Efficacy and Safety of Fluticasone Furoate Inhalation Powder and Fluticasone Propionate Inhalation Powder in the Treatment of Asthma in Adults and Adolescents Not Currently Treated With Inhaled Corticosteroids

GlaxoSmithKline·interventional·Posted Sep 19, 2011·Updated Jan 9, 2017

In Brief

A Phase 3 clinical trial evaluating Fluticasone furoate 50mcg, Fluticasone propionate 100mcg, and 1 other intervention for Asthma. Completed, enrolled 351 participants across 42 sites in 6 countries.

Detailed Summary

A randomised, double-blind, double-dummy, placebo controlled multi-centre study to evaluate the efficacy and safety of fluticasone furoate inhalation powder and fluticasone propionate inhalation powder in the treatment of asthma in adults and adolescents not currently treated with inhaled corticosteroids

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAsthma
CountriesMexico, Netherlands, Peru, Poland, Russia, United States
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 19, 2011
Enrollment StartSep 1, 2011
Primary CompletionSep 1, 2012
TodayJul 2, 2026
Enrollment to primary: 1 yearPosted 14.8 years ago

Interventions

Fluticasone furoate 50mcgdrug

Once daily inhalation powder via Novel Dry Powder Inhaler

Fluticasone propionate 100mcgdrug

Twice daily inhalation powder via DISKUS/ACCUHALER

Placebodrug

Inhalation powder via Novel Dry Powder Inhaler and DISKUS?ACCUHALER